# HSG

> HSG is a VC fund in Beijing backing Health Care and Biotechnology. See 751 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 751
- Last investment: Sep 2025
- Lead investor: 42%
- Last fund: Jul 2024
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/10364459/
- Website: https://www.sequoiacap.com/china/en/

HSG is a VC fund in Beijing focused on Health Care and Biotechnology. HSG, formerly known as Sequoia Capital China, is a leading venture capital and private equity firm investing globally in the technology, healthcare, and consumer sectors. With offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, HSG manages over 55 billion USD in assets across various funds for top institutionalinvestors.Founded in 2005, HSG has nurtured entrepreneurship and innovation, backing more than 1,500 companies with transformative technologies, disruptive business models, and high-growth potential. To date, more than 160 HSG portfolio companies have listed on public stock exchanges, while over 140 private portfolio companies have reached unicorn status.Throughout the past two decades, HSG has evolved into a fully integrated investment platform spanning seed, venture, growth, buyout, and infrastructure investing, as well as public equities investment.HSG is committed to helping founders and companies build legendary companies that endure while consistently generating superior returns for our limited partners. By partnering with HSG, companies benefit from HSG’s extensive resources, including a robust entrepreneurial community and industry expertise.

## Contacts

5 contacts available for HSG. Shizune tracks 9 team members at HSG. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/sequoia-capital-china?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $4.4M–$100M |
| Series B | $12M–$200M |
| Series C | $26M–$214M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 71 | 9% |
| Biotechnology | 69 | 9% |
| Software | 67 | 9% |
| Artificial Intelligence | 67 | 9% |
| Medical | 55 | 7% |

328 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 202 | 27% |
| Series B | 166 | 22% |
| Series C | 90 | 12% |
| Seed | 87 | 12% |
| Series D | 42 | 6% |

17 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 438 | 58% |
| United States | 46 | 6% |
| Hong Kong | 11 | 1% |
| Australia | 8 | 1% |
| Singapore | 8 | 1% |

17 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Cen Wang | Partner | 4 | https://shizune.co/investors/profile/cen-wang-a863 |
| Cherry Lu | Partner | 0 | https://shizune.co/investors/profile/cherry-lu |
| Don Valentine | Founder | 0 | https://shizune.co/investors/profile/don-valentine-9f39 |
| Enita Pu | Partner | 0 | https://shizune.co/investors/profile/enita-pu |
| Eva Ip | CFO | 0 | https://shizune.co/investors/profile/eva-ip |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| MarqVision | MarqVision helps global brands remove counterfeits from online marketplaces. | $48M | Series B | Sep 15, 2025 |  |
| Yunzhou Zhiwei | Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence. |  | Seed | Aug 22, 2025 |  |
| Eight Sleep | Eight Sleep is a company that creates sleep technology and products. Its core product, the Pod, is a smart sleep system that dynamically adjusts temperature, elevation, and sound based on biometrics. The system also includes a health check feature that monitors heart rate and breathing without wearable devices. | $100M | Series D | Aug 19, 2025 |  |
| Midas | Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks. | $80M | Series B | Aug 19, 2025 |  |
| Xunlu Innovation | Xunlu Innovation is a cutting-edge bicycle manufacturer based in Shenzhen, China, specializing in intelligent electric cargo bikes designed to meet modern urban mobility needs. |  | Series A | Aug 08, 2025 |  |
| Excalipoint Therapetics | Excalipoint Therapeutics is a Private limited company. |  | Series A | Aug 04, 2025 |  |
| OpenMind | OpenMind is a software company that develops an operating system for robots and intelligent machines. | $20M | Series A | Aug 04, 2025 |  |
| Creao AI | Creao AI is a leading provider of AI-powered agent automation and virtual environments, specializing in the development of intelligent systems that streamline business operations, enhance user interactions, and simulate realistic digital experiences. |  | Seed | Jul 31, 2025 |  |
| RD Technologies | RD Wallet is a licenced Stored Value Facility in Hong Kong. It is the first business-focused, multiple-currency mobile wallet. RD Wallet offers deposits, local and cross-border payments and foreign exchange services for businesses. | $40M | Series A | Jul 30, 2025 |  |
| Tongxin Medical Equipment | Tongxin makes magnetically-suspended artificial blood pumps which are designed to replace the human heart. They are undergoing clinical trials in China after being fast-tracked through the approval process by the National Medical Products Administration, state-run Xinhua News Agency | $100M | Venture - Series Unknown | Jul 21, 2025 |  |

10 of 751 investments shown.

## Co-investors
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 421 deals together
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 66 deals together
- [Tencent](https://shizune.co/investors/profile/tencent) — VC Fund, 44 deals together
- [Hillhouse Investment](https://shizune.co/investors/profile/hillhouse-capital) — VC Fund, 36 deals together
- [ZhenFund](https://shizune.co/investors/profile/zhenfund) — VC Fund, 33 deals together
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 32 deals together

## Similar investors

### Similar industry
- [Coinbase Ventures](https://shizune.co/investors/profile/coinbase-ventures) — VC Fund
- [Animoca Brands](https://shizune.co/investors/profile/animoca-brands-corporation) — VC Fund
- [Digital Currency Group](https://shizune.co/investors/profile/digital-currency-group) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund

## Featured in investor lists
- [All Investors](https://shizune.co/investors/investors)
- [All Investors in Asia](https://shizune.co/investors/investors-asia)
- [All VC Funds in Asia](https://shizune.co/investors/vc-funds-asia)
- [All Investors in China](https://shizune.co/investors/investors-china)
- [All VC Funds in China](https://shizune.co/investors/vc-funds-china)
- [SaaS Investors in Asia](https://shizune.co/investors/saas-investors-asia)

## FAQ

### What does HSG invest in?

HSG invests primarily in Health Care, Biotechnology and Software startups, most often at Series A and Series B stage. Most of the 751 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is HSG's check size?

HSG typically joins rounds of $4.4M–$100M at Series A, $12M–$200M at Series B and $26M–$214M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HSG participates in.

### How do I contact HSG?

Public channels for HSG include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at HSG?

The team at HSG includes Cen Wang (Partner), Cherry Lu (Partner) and Don Valentine (Founder), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co